Wikidata

(Q46004672)

English

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19455333
retrieved
18 December 2017
reference URL
http://europepmc.org/abstract/MED/19455333

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46004672&oldid=2207521141"